Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering
– $55 million Series A financing will advance the company’s robust preclinical pipeline and ongoing discovery efforts – – Epic holds exclusive license to smallest known Cas protein, enabling in vivo delivery via AAV vector to wide range of target organs – – Lead program in facioscapulohumeral muscular dystrophy (FSHD) on track for clinical initiation … Read more